Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10

Inflammation

Volumn 27, Issue 4, 2003, Pages 161-174

  Fine, Jay S ^a   Rojas Triana, Alberto ^a   Jackson, James V ^a   Engstrom, Laura W ^a   Deno, Gregory S ^a   Lundell, Daniel J ^a   Bober, Loretta A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Chemokine; Cytokine; Leukocyte trafficking; Pleuritis

Indexed keywords

CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXUDATE; FEMALE; IN VIVO STUDY; LEUKOCYTE MIGRATION; LYMPHOCYTE MIGRATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PLEURA CAVITY; PLEURISY; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH1 CELL; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LEUKOCYTES; MICE; PLEURAL CAVITY; PLEURISY; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE;

ANIMALIA; MURINAE;

EID: 0041382826     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025076111950     Document Type: Article

References (37)

1. Gerard, C. and B. J. Rollins. 2001. Chemokines and disease. Nat. Immunol. 2:108-115.
2. Mckay, C. R. 2001. Chemokines: Immunology's high impact factors. Nat. Immunol. 2:95-101.
3. Feldmann, M. 2001. Pathogenesis of arthritis: Recent research progress. Nat. Immunol. 2:771-773.
4. Davidson, A. and B. J. Diamond. 2001. Autoimmune diseases. N. Engl. J. Med. 345:340-350.
5. Brandtzaeg, P., G. Haraldsen, and J. Rugtveit. 1997. Immunopathology of human inflammatory bowel disease. Springer Semin. Immunopathol. 18:555-589.
6. Locati, M. and P. M. Murphy. 1999. Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50:425-440.
7. Crowle, A. J., C. C. Hu, and A. Patrucco. 1968. Preferential development by mice of delayed hypersensitivity to purified basic proteins. J. Allergy 42:140-156.
8. Teixeira, M. M., A. Talvani, W. L. Tafuri, N. W. Lukacs, and P. G. Hellewell. 2001. Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice. J. Leukoc. Biol. 69:353-360.
9. Lewis, A. J., J. Parker, J. DiLuigi, L. J. Datko, and R. P. Carlson. 1982. Immunomodulation of delayed hypersensitivity to methylated bovine serum albumin (mBSA) in mice using subliminal and normal sensitization procedures. J. Immunopharmacol. 3:289-307.
10. Yoshino, S. and J. Yoshino. 1998. Effect of a monoclonal antibody against interleukin-4 on suppression of antigen-induced arthritis in mice by oral administration of the inducing antigen. Cell Immunol. 187:139-144.
11. Brackertz, D., G. F. Mitchell, and I. R. Mackay. 1977. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum. 20:841-850.
12. Van Lent, P. L., A. J. van Vuuren, A. B. Blom, A. E. Holthuysen, L. B. van de Putte, J. G. van de Winkel, and W. B. van den Berg. 2000. Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis. Arthritis Rheum. 43:740-752.
13. Van Lent, P. L., K. Nabbe, A. B. Blom, A. E. Holthuysen, A. Sloetjes, L. B. van de Putte, S. Verbeek, and W. B. van den Berg. 2001. Role of activatory FcγRI and FcγRII and inhibitory FcγRIII in inflammation and cartilage destruction during experimental antigen-induced arthritis. Am. J. Pathol. 159:2309-2320.
14. De Hooge, A. S. K., F. A. J. van de Loo, O. J. Arntz, and W. B. van den Berg. 2001. Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis. Am. J. Pathol. 157:2081-2091.
15. van de Loo, F. A., L. A. Joosten, P. L. van Lent, O. J. Arntz, and W. B. van den Berg. 1995. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38:164-172.
16. Dunn, C. J. and S. K. Miller. 1986. The effects of cyclosprorin A on leucocyte infiltration and procoagulant activity in the mouse delayed hypersensitivity response in vivo. Int. J. Immunopharmacol. 8:635-643.
17. Fine, J. S., J. V. Jackson, A. Rojas-Triana, and L. A. Bober. 2000. Evaluation of chemokine- and phlogisitin-mediated leukocyte chemotaxis using an in vivo sponge model. Inflammation 24:331-346.
18. Chomarat, P. and J. Banchereau. 1998. Interleukin-4 and interleukin-13: Their similarities and discrepancies. Int. Rev. Immunol. 17:1-52.
19. Mosmann, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1-26.
20. Jung, T. M., W. M. Gallatin, I. L. Weissman, and M. O. Dailey. 1988. Down-regulation of homing receptors after T cell activation. J. Immunol. 141:4110-4117.
21. + memory T cells from the spleen lack MEL-14, the lymph node homing receptor. J. Immunol. 148:324-331.
22. + T cells after alloantigen exposure. Immunology 75:632-638.
23. Schall, T. J., J. Jongstra, B. J. Dyer, J. Jorgensen, C. Clayberger, M. M. Davis, and A. M. Krensky. 1988. A human T cell-specific molecule is a new member of a new gene family. J. Immunol. 141:1018-1025.
24. Lee, Y. C. and K. B. Lane. 2001. The many faces of transforming growth factor-beta in pleural diseases. Curr. Opin. Plum. Med. 7:173-179.
25. Peretti, M., C. Szabo, and C. Thiemermann. 1995. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br. J. Pharmacol. 116:2251-2257.
26. Bober, L. A., A. Rojas-Triana, J. V. Jackson, M. W. Leach, D. Manfra, S. K. Narula, and M. J. Grace. 2000. Regulatory effects of interleukin-4 and interleukin-10 on human neutrophil function ex vivo and on neutrophil influx in a rat model of arthritis. Arthritis Rheum. 43:2660-2667.
27. Powrie, F., S. Menon, and R. L. Coffman. 1993. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:2223-2229.
28. Yano, S., H. Yanagawa, Y. Nishioka, N. Mukaida, K. Matsushima, and S. Sone. 1996. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J. Immunol. 157:2660-2665.
29. van Wely, C. A., P. C. L. Beverley, S. J. Brett, C. Britten, and J. P. Tite. 1999. Expression of L-selectin on Th1 cells is regulated by IL-12. J. Immunol. 163:1214-1221.
30. Carlow, D. A., S. Y. Corbel, M. J. Williams, and H. J. Ziltener. 2001. IL-2, -4 and -15 differentially regulate O-glycan brancing and P-selectin ligand formation in activated CD8 T cells. J. Immunol. 167:6841-6848.
31. Chao, C. C., R. Jensen, and M. O. Dailey. 1997. Mechanisms of L-selectin regulation by activated T cells. J. Immunol. 159:1686-1694.
32. D'Amico, G., G. Frascaroli, G. Bianchi, P. Tansidico, A. Doni, A. Vecchi, S. Sozzani, P. Allavena, and A. Mantovani. 2000. Uncoupling of inflammatory chemokine receptors by IL-10: Generation of functional decoys. Nat. Immunol. 1:387-391.
33. Biedermann, T., M. Kneilling, R. Mailhammer, K. Maier, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. 2000. Mast cells control neutrophil recruitment during T-cell mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192:1441-1452.
34. Piguet, P. F., G. E. Grau, C. Hauser, and P. Vassalli. 1991. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J. Exp. Med. 173:673-679.
35. Chu, A., K. Hong, E. L. Berg, and R. O. Ehrhardt. 1999. Tissue specificity of E-and P-selecfin ligands in Th1-mediated chronic inflammation. J. Immunol. 163:5086-5093.
36. + lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164:6303-6312.
37. De Jong, P., A. C. Abadia-Molina, A. R. Satoskar, K. Clarke, S. T. Rietdijk, W. A. Faubion, E. Mizoguchi, C. N. Metz, M. Al Sahli, T. ten Hove, A. C. Keates, J. B. Lubetsky, R. J. Farrell, P. Michetti, S. J. van Deventer, E. Lolis, J. R. David, A. K. Bhan, and C. Terhorst 2001. Development of chronic colitis is dependent on the cytokine MIF. Nat. Immunol. 2:1061-1066.